Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study.
Saved in:
| Title: | Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study. |
|---|---|
| Authors: | Mao, Chenyu1 (AUTHOR), Xiong, Anwen2 (AUTHOR), Qian, Jiong1 (AUTHOR), Wang, Wenxiang3 (AUTHOR), Liu, Ying4 (AUTHOR), Zhang, Tao5 (AUTHOR), Wu, Zhihai6 (AUTHOR), Ni, Haiqing6 (AUTHOR), Lu, Jia6 (AUTHOR), Long, Sixiang6 (AUTHOR), Zhao, Li6 (AUTHOR), Chen, Yuling6 (AUTHOR), Zhou, Caicun2 (AUTHOR) caicunzhoudr@163.com, Xu, Nong1 (AUTHOR) nongxu@zju.edu.cn |
| Source: | Journal of Hematology & Oncology. 12/31/2024, Vol. 17 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
